Stellantis Q2 Profits Spark Optimism, But Turnaround Unproven

What happened

Stellantis’ second-quarter profits improved markedly, driven by North America shipment growth and cost controls, yet the underlying European operations still grapple with deep overcapacity and EV price wars. While the $13B U.S. reinvestment begins to bear fruit with Ram and Jeep volume gains, Italian plants remain deeply underutilized and small-EV pricing continues to erode. The combined narrative—strong Q2 versus unresolved European drag—mirrors the mixed signals that prompted our WAIT rating, which awaits sustained free-cash-flow recovery. Governance flux persists with a still-interim CEO, reducing conviction that short-term profit spikes will translate into durable earnings growth. Until there is clear evidence that Europe can stabilize without massive discounting, the recent profit beat is more a relief rally opportunity than a signal to buy.

Implication

For investors, the Q2 profit beat provides a positive data point but does not alter the core risks: European overcapacity keeps utilization and margins under pressure, while U.S. reinvestment returns are still nascent. The stock may trade up on short-term optimism, but the structural challenges—EV price compression, Italian plant fragility, and CEO vacancy—persist. A sustained turnaround would require at least two more quarters of improving industrial free cash flow and a credible plan at the upcoming Capital Markets Day to address European underperformance. Premature buying risks getting caught in another value trap if the next quarter disappoints. We advise waiting for H2 2025 results (already passed per our report) and the 2026 Capital Markets Day for clearer signals before committing capital.

Thesis delta

Stellantis’ Q2 profit beat modestly raises the probability of the U.S. turnaround scenario, but European headwinds and lack of a permanent CEO keep the thesis unchanged. The WAIT rating stands, with a minor positive tilt that requires subsequent quarters to confirm the recovery path. The 2026 Capital Markets Day is now the pivotal event to validate the investment case.